Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Smooth Muscle | 7 | 2016 | 144 | 2.310 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2016 | 317 | 1.630 |
Why?
|
| Angioplasty, Balloon | 5 | 2020 | 110 | 1.420 |
Why?
|
| Polyethylenes | 7 | 2006 | 31 | 1.380 |
Why?
|
| Arthroplasty, Replacement, Knee | 5 | 2017 | 146 | 1.300 |
Why?
|
| Biocompatible Materials | 11 | 2006 | 247 | 1.270 |
Why?
|
| Materials Testing | 11 | 2006 | 263 | 1.060 |
Why?
|
| Actins | 4 | 2011 | 249 | 0.810 |
Why?
|
| Stents | 5 | 2020 | 657 | 0.780 |
Why?
|
| Femur | 5 | 2017 | 113 | 0.730 |
Why?
|
| Cell Proliferation | 5 | 2016 | 1174 | 0.710 |
Why?
|
| Joint Prosthesis | 3 | 2017 | 48 | 0.690 |
Why?
|
| Tibia | 3 | 2017 | 93 | 0.680 |
Why?
|
| Stress, Mechanical | 11 | 2016 | 208 | 0.680 |
Why?
|
| Mechanotransduction, Cellular | 3 | 2016 | 27 | 0.650 |
Why?
|
| Equipment Failure Analysis | 4 | 2009 | 121 | 0.610 |
Why?
|
| Knee Prosthesis | 4 | 2009 | 64 | 0.590 |
Why?
|
| Mechanical Phenomena | 1 | 2017 | 21 | 0.590 |
Why?
|
| Pressure | 3 | 2017 | 252 | 0.590 |
Why?
|
| Rotation | 1 | 2017 | 58 | 0.590 |
Why?
|
| Surface Properties | 12 | 2011 | 363 | 0.510 |
Why?
|
| Hyaluronic Acid | 2 | 2006 | 206 | 0.490 |
Why?
|
| Glucose | 1 | 2016 | 307 | 0.470 |
Why?
|
| Vascular Access Devices | 1 | 2014 | 21 | 0.460 |
Why?
|
| Drug-Eluting Stents | 1 | 2014 | 51 | 0.450 |
Why?
|
| Knee Joint | 3 | 2009 | 115 | 0.440 |
Why?
|
| Nickel | 1 | 2011 | 18 | 0.390 |
Why?
|
| Cartilage, Articular | 5 | 1995 | 38 | 0.390 |
Why?
|
| Stainless Steel | 1 | 2011 | 31 | 0.380 |
Why?
|
| Cells, Cultured | 8 | 2016 | 2673 | 0.380 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2016 | 2083 | 0.360 |
Why?
|
| Animals | 21 | 2020 | 20881 | 0.330 |
Why?
|
| Microscopy, Atomic Force | 3 | 2003 | 66 | 0.330 |
Why?
|
| Cell Shape | 3 | 2016 | 37 | 0.330 |
Why?
|
| Muscle Relaxation | 1 | 2009 | 31 | 0.330 |
Why?
|
| Rats | 8 | 2020 | 5300 | 0.320 |
Why?
|
| Microtubules | 1 | 2009 | 104 | 0.320 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 35 | 0.320 |
Why?
|
| Phenotype | 4 | 2016 | 947 | 0.310 |
Why?
|
| Synovial Fluid | 2 | 2006 | 16 | 0.300 |
Why?
|
| Models, Cardiovascular | 1 | 2008 | 133 | 0.300 |
Why?
|
| Sterilization | 5 | 2007 | 29 | 0.290 |
Why?
|
| Polyethylene | 2 | 2009 | 31 | 0.290 |
Why?
|
| Apoptosis | 2 | 2016 | 1641 | 0.290 |
Why?
|
| Hyperplasia | 2 | 2009 | 89 | 0.290 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 189 | 0.280 |
Why?
|
| Titanium | 3 | 2011 | 118 | 0.280 |
Why?
|
| Biomimetic Materials | 1 | 2006 | 20 | 0.270 |
Why?
|
| Friction | 5 | 2006 | 16 | 0.270 |
Why?
|
| Hip Prosthesis | 2 | 1996 | 85 | 0.250 |
Why?
|
| Elasticity | 6 | 2009 | 103 | 0.250 |
Why?
|
| Alloys | 3 | 2011 | 66 | 0.240 |
Why?
|
| Biomechanical Phenomena | 5 | 2017 | 368 | 0.240 |
Why?
|
| Aorta | 5 | 2011 | 316 | 0.230 |
Why?
|
| Phosphorylcholine | 1 | 2003 | 12 | 0.230 |
Why?
|
| Methacrylates | 1 | 2003 | 31 | 0.230 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2003 | 54 | 0.220 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2003 | 59 | 0.220 |
Why?
|
| Lubrication | 4 | 2006 | 8 | 0.220 |
Why?
|
| Dipeptides | 1 | 2003 | 89 | 0.220 |
Why?
|
| Proteoglycans | 1 | 2003 | 103 | 0.220 |
Why?
|
| Muscle Proteins | 2 | 2016 | 94 | 0.220 |
Why?
|
| Biomarkers | 3 | 2016 | 1593 | 0.210 |
Why?
|
| Catheterization | 1 | 2003 | 209 | 0.210 |
Why?
|
| Models, Chemical | 1 | 2004 | 155 | 0.210 |
Why?
|
| Arteries | 1 | 2003 | 108 | 0.210 |
Why?
|
| Catheters, Indwelling | 1 | 2002 | 72 | 0.210 |
Why?
|
| Hypertrophy | 2 | 2016 | 89 | 0.210 |
Why?
|
| Water | 1 | 2003 | 230 | 0.210 |
Why?
|
| Tunica Intima | 1 | 2002 | 59 | 0.210 |
Why?
|
| Blood Vessels | 1 | 2002 | 102 | 0.210 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2002 | 73 | 0.210 |
Why?
|
| Linear Models | 3 | 2011 | 521 | 0.200 |
Why?
|
| Knee | 1 | 2002 | 17 | 0.200 |
Why?
|
| Carbon Dioxide | 3 | 2007 | 78 | 0.200 |
Why?
|
| Calcinosis | 1 | 2003 | 241 | 0.200 |
Why?
|
| Temperature | 2 | 2007 | 341 | 0.200 |
Why?
|
| Time Factors | 5 | 2016 | 4655 | 0.190 |
Why?
|
| Paclitaxel | 2 | 2014 | 140 | 0.190 |
Why?
|
| Locomotion | 1 | 2002 | 135 | 0.190 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2011 | 236 | 0.190 |
Why?
|
| Vascular Surgical Procedures | 1 | 2002 | 168 | 0.190 |
Why?
|
| Cell Movement | 1 | 2003 | 630 | 0.180 |
Why?
|
| Swine | 4 | 2020 | 672 | 0.180 |
Why?
|
| Coronary Restenosis | 1 | 2020 | 42 | 0.180 |
Why?
|
| Durapatite | 1 | 1999 | 33 | 0.170 |
Why?
|
| Gentamicins | 1 | 1999 | 68 | 0.170 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2020 | 178 | 0.170 |
Why?
|
| Endothelium, Vascular | 3 | 2009 | 371 | 0.160 |
Why?
|
| Computer Simulation | 3 | 2008 | 706 | 0.160 |
Why?
|
| Food, Formulated | 1 | 1998 | 11 | 0.160 |
Why?
|
| Fractures, Bone | 1 | 1999 | 132 | 0.160 |
Why?
|
| Silicones | 1 | 1998 | 32 | 0.160 |
Why?
|
| Prostheses and Implants | 3 | 2006 | 159 | 0.150 |
Why?
|
| Viscosity | 2 | 2009 | 72 | 0.150 |
Why?
|
| Sirolimus | 2 | 2020 | 118 | 0.150 |
Why?
|
| Prosthesis Design | 2 | 2011 | 301 | 0.150 |
Why?
|
| Cell Adhesion | 2 | 2009 | 324 | 0.150 |
Why?
|
| Drug Delivery Systems | 1 | 1999 | 236 | 0.150 |
Why?
|
| Finite Element Analysis | 1 | 2017 | 55 | 0.150 |
Why?
|
| Femur Head | 1 | 1996 | 17 | 0.140 |
Why?
|
| Enteral Nutrition | 1 | 1998 | 157 | 0.140 |
Why?
|
| Hardness | 2 | 2008 | 20 | 0.140 |
Why?
|
| Lipids | 1 | 1998 | 298 | 0.140 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 1995 | 9 | 0.130 |
Why?
|
| Rubber | 1 | 1995 | 13 | 0.130 |
Why?
|
| Polyurethanes | 1 | 1995 | 21 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 102 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2011 | 1753 | 0.130 |
Why?
|
| Chemical Engineering | 1 | 1995 | 1 | 0.130 |
Why?
|
| Cattle | 4 | 2006 | 475 | 0.120 |
Why?
|
| Weight-Bearing | 3 | 2003 | 53 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 507 | 0.110 |
Why?
|
| Cell Size | 3 | 2009 | 76 | 0.110 |
Why?
|
| Iohexol | 1 | 2014 | 82 | 0.110 |
Why?
|
| Cartilage Diseases | 1 | 1993 | 10 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2003 | 2550 | 0.110 |
Why?
|
| Phosphatidylcholines | 1 | 1993 | 38 | 0.110 |
Why?
|
| Reproducibility of Results | 4 | 2009 | 2077 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 1999 | 1026 | 0.110 |
Why?
|
| Equipment Design | 2 | 2007 | 500 | 0.100 |
Why?
|
| Humans | 12 | 2017 | 68618 | 0.100 |
Why?
|
| Collagen | 1 | 1994 | 636 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 282 | 0.090 |
Why?
|
| Chromium Alloys | 1 | 1990 | 16 | 0.090 |
Why?
|
| Curriculum | 1 | 1995 | 575 | 0.090 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 337 | 0.090 |
Why?
|
| Spores, Bacterial | 2 | 2007 | 17 | 0.090 |
Why?
|
| DNA | 2 | 2003 | 597 | 0.090 |
Why?
|
| Bacillus | 2 | 2007 | 5 | 0.090 |
Why?
|
| Vimentin | 1 | 2009 | 47 | 0.090 |
Why?
|
| Models, Animal | 2 | 2007 | 252 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 160 | 0.080 |
Why?
|
| Cytochalasin D | 1 | 2009 | 10 | 0.080 |
Why?
|
| Nocodazole | 1 | 2009 | 11 | 0.080 |
Why?
|
| Tubulin Modulators | 1 | 2009 | 10 | 0.080 |
Why?
|
| Hydrogen Peroxide | 2 | 2007 | 168 | 0.080 |
Why?
|
| Female | 5 | 2016 | 38074 | 0.080 |
Why?
|
| Depsipeptides | 1 | 2009 | 21 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1040 | 0.080 |
Why?
|
| Constriction, Pathologic | 1 | 2009 | 236 | 0.080 |
Why?
|
| Models, Biological | 2 | 2009 | 981 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2003 | 765 | 0.080 |
Why?
|
| Pulsatile Flow | 1 | 2007 | 20 | 0.080 |
Why?
|
| Powders | 2 | 2002 | 32 | 0.070 |
Why?
|
| Serum | 1 | 2006 | 24 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2007 | 954 | 0.060 |
Why?
|
| Tensile Strength | 2 | 2003 | 90 | 0.060 |
Why?
|
| Prosthesis-Related Infections | 1 | 2005 | 70 | 0.060 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2004 | 13 | 0.060 |
Why?
|
| Nanotubes | 1 | 2004 | 22 | 0.060 |
Why?
|
| Polyglycolic Acid | 1 | 2003 | 20 | 0.060 |
Why?
|
| Cross-Linking Reagents | 1 | 2004 | 80 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2007 | 4848 | 0.060 |
Why?
|
| Cell Line | 1 | 2007 | 1752 | 0.060 |
Why?
|
| Iliac Artery | 1 | 2003 | 44 | 0.060 |
Why?
|
| Dinucleoside Phosphates | 1 | 2003 | 2 | 0.050 |
Why?
|
| Nitroso Compounds | 1 | 2003 | 16 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2003 | 86 | 0.050 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2002 | 72 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 541 | 0.050 |
Why?
|
| Goats | 2 | 1999 | 17 | 0.050 |
Why?
|
| Compressive Strength | 1 | 2002 | 17 | 0.050 |
Why?
|
| Torque | 1 | 2002 | 34 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2002 | 216 | 0.050 |
Why?
|
| Polymers | 1 | 2003 | 244 | 0.050 |
Why?
|
| Dogs | 2 | 1993 | 490 | 0.050 |
Why?
|
| Artifacts | 1 | 2002 | 125 | 0.050 |
Why?
|
| Nanotechnology | 1 | 2002 | 109 | 0.050 |
Why?
|
| Movement | 1 | 2002 | 179 | 0.050 |
Why?
|
| Male | 4 | 2009 | 37321 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2002 | 186 | 0.050 |
Why?
|
| Neointima | 1 | 2020 | 7 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2002 | 319 | 0.040 |
Why?
|
| Calcium Phosphates | 1 | 1999 | 13 | 0.040 |
Why?
|
| Osseointegration | 1 | 1999 | 19 | 0.040 |
Why?
|
| Aged | 3 | 2009 | 14862 | 0.040 |
Why?
|
| Heparin | 1 | 2020 | 205 | 0.040 |
Why?
|
| Polyesters | 1 | 1998 | 55 | 0.040 |
Why?
|
| Wound Healing | 1 | 1999 | 260 | 0.040 |
Why?
|
| Middle Aged | 3 | 2009 | 21147 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 1851 | 0.040 |
Why?
|
| Legg-Calve-Perthes Disease | 1 | 1995 | 4 | 0.030 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 1995 | 4 | 0.030 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1995 | 28 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 3259 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1995 | 112 | 0.030 |
Why?
|
| Tissue Embedding | 1 | 1994 | 4 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2002 | 1615 | 0.030 |
Why?
|
| Porosity | 1 | 1994 | 63 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 272 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1994 | 254 | 0.030 |
Why?
|
| Particle Size | 1 | 1994 | 201 | 0.030 |
Why?
|
| Forecasting | 1 | 1995 | 277 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 1994 | 261 | 0.030 |
Why?
|
| Patella | 1 | 1992 | 14 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 219 | 0.020 |
Why?
|
| Reference Values | 2 | 2003 | 579 | 0.020 |
Why?
|
| Metals | 1 | 1992 | 100 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 1990 | 21 | 0.020 |
Why?
|
| Cell Survival | 2 | 2003 | 901 | 0.020 |
Why?
|
| Geobacillus stearothermophilus | 1 | 2007 | 9 | 0.020 |
Why?
|
| 2-Propanol | 1 | 2006 | 4 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2005 | 130 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 1996 | 7277 | 0.010 |
Why?
|
| Triazenes | 1 | 2003 | 1 | 0.010 |
Why?
|
| Culture Media | 1 | 2003 | 155 | 0.010 |
Why?
|
| Nitric Oxide Donors | 1 | 2003 | 54 | 0.010 |
Why?
|
| Cell Count | 1 | 2003 | 248 | 0.010 |
Why?
|
| Ethanol | 1 | 2006 | 893 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1745 | 0.010 |
Why?
|
| Absorption | 1 | 1998 | 49 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1998 | 169 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1998 | 358 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1998 | 420 | 0.010 |
Why?
|
| Orchiectomy | 1 | 1995 | 25 | 0.010 |
Why?
|
| Radiography | 1 | 1995 | 572 | 0.010 |
Why?
|
| Adult | 1 | 2009 | 21403 | 0.010 |
Why?
|